One-year outcomes following implantation of second-generation trabecular micro-bypass stents in conjunction with cataract surgery for various types of glaucoma or ocular hypertension: multicenter, multi-surgeon study
One-year outcomes following implantation of second-generation trabecular micro-bypass stents in conjunction with cataract surgery for various types of glaucoma or ocular hypertension: multicenter, multi-surgeon study
复制标题
DOI：
10.2147/opth.s187272
复制
发表时间：
2019-01-01
影响因子：
2.2
通讯作者：
Manninge, David
中科院分区：
文献类型：
--
作者：
Clement, Colin, I;Howes, Frank;Manninge, David
目的：评估轻度至晚期青光眼或高眼压（OHT）白内障术后植入两种第二代小梁微搭桥支架的有效性和安全性。患者和方法：回顾性研究澳大利亚5位外科医生在5个地点进行的iStent (R)注射小梁微搭桥白内障手术。眼睛有轻度到晚期青光眼（主要是原发性开角、对位闭角或假剥脱性青光眼）或OHT和需要手术的白内障。疗效指标包括眼内压（IOP）；药物负担;无药物治疗的眼睛比例，>= 2药物治疗，与术前相比药物治疗稳定或减少，以及IOP
Purpose: To assess the utility and safety of implanting two second-generation trabecular micro-bypass stents following cataract surgery in eyes with mild to advanced glaucoma or ocular hypertension (OHT).Patients and methods: Retrospective study of iStent (R) inject trabecular micro-bypass implantation with cataract surgery by five surgeons at five sites in Australia. Eyes had mild to advanced glaucoma (predominantly primary open-angle, appositional angle-closure, or pseudoexfoliative glaucoma) or OHT and cataract requiring surgery. Effectiveness measures included intraocular pressure (IOP); medication burden; and proportions of eyes with no medications, >= 2 medications, stable or decreased medications vs preoperative, and IOP